Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Rheumatoid Arthritis

  Free Subscription


11.05.2025

4 Ann Rheum Dis
1 Arthritis Res Ther
2 Clin Exp Immunol
1 Clin Exp Rheumatol
1 Rheumatol Int
1 Scand J Rheumatol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. WIENTJES MHM, Atiqi S, Wolbink GJ, Nurmohamed MT, et al
    Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial.
    Ann Rheum Dis. 2025 May 2:S0003-4967(25)00885-4. doi: 10.1016/j.ard.2025.
    PubMed         Abstract available

  2. JAJODIA A, Mishra A, Doni Jayavelu N, Lambert K, et al
    Functional dissection of noncoding variants associated with rheumatoid arthritis.
    Ann Rheum Dis. 2025 May 2:S0003-4967(25)00890-8. doi: 10.1016/j.ard.2025.
    PubMed         Abstract available

  3. NASH P, Kerschbaumer A, Konzett V, Aletaha D, et al
    Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update.
    Ann Rheum Dis. 2025;84:664-679.
    PubMed         Abstract available

  4. KONZETT V, Smolen JS, Nash P, Aletaha D, et al
    Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement.
    Ann Rheum Dis. 2025;84:680-696.
    PubMed         Abstract available


    Arthritis Res Ther

  5. VAN WESEMAEL TJ, Morton FR, Heutz JW, Maurits MP, et al
    Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:101.
    PubMed         Abstract available


    Clin Exp Immunol

  6. DE JONG TA, Semmelink JF, Bolt JW, Grasso C, et al
    Senolytic treatment to rescue hallmarks of senescence in lymph node fibroblasts from patients with rheumatoid arthritis: Implications for premature aging and potential therapeutic intervention in early rheumatoid arthritis.
    Clin Exp Immunol. 2025 May 8:uxaf029. doi: 10.1093.
    PubMed         Abstract available

  7. FRESNEDA ALARCON M, Abdullah GA, Nolan A, Linford C, et al
    The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production, and NET release.
    Clin Exp Immunol. 2025;219:uxaf012.
    PubMed         Abstract available


    Clin Exp Rheumatol

  8. ROSSI A, Ferrari G, Galli V, Bonacini M, et al
    Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2025;43:809-814.
    PubMed         Abstract available


    Rheumatol Int

  9. BRYANT MJ, Lester S, Russell O, Whittle S, et al
    Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients.
    Rheumatol Int. 2025;45:138.
    PubMed         Abstract available


    Scand J Rheumatol

  10. LI CH, Gao JL, Ren C, Yang SM, et al
    Synovial chondromatosis in a patient with atypical rheumatoid arthritis confirmed by clinical, radiographic, and pathological evidence: a case report.
    Scand J Rheumatol. 2025 May 9:1-3. doi: 10.1080/03009742.2025.2491181.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.